An update on cardiac implantable electronic devices for the general physician

Cardiac electronic device implantation is a common and important intervention for patients with tachy-and bradyarrhythmia. An increasing number of patients are receiving more complex devices such as cardiac resynchronisation therapy or devices with a defibrillation function. Over the last 5 years, t...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of the Royal College of Physicians of Edinburgh Vol. 48; no. 2; pp. 141 - 147
Main Authors Peal, J E, Mathews, I G, Runnett, C, Thomas, H E, Ripley, D P
Format Journal Article
LanguageEnglish
Published Scotland 01.06.2018
Subjects
Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - therapy
Cardiac Resynchronization Therapy Devices - adverse effects
Defibrillators, Implantable - adverse effects
General Practice
Humans
Syncope - therapy
biventricular pacing
pacemaker
cardiac pacing
cardiac resynchronisation pacing therapy
implantable defibrillators
Online AccessGet full text

Cover

More Information
Summary:Cardiac electronic device implantation is a common and important intervention for patients with tachy-and bradyarrhythmia. An increasing number of patients are receiving more complex devices such as cardiac resynchronisation therapy or devices with a defibrillation function. Over the last 5 years, two new models of cardiac device have emerged, subcutaneous defibrillators and leadless pacemakers. With an ageing population and data demonstrating 2000 per 100,000 of the population aged over 75 years have a cardiac device, it is essential that the general physician remains updated on the common pacemaker indications and available therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1478-2715
2042-8189
DOI:10.4997/JRCPE.2018.208